Similar articles

• Complement C3 is a novel plasma clot component with anti-fibrinolytic properties.

  Howes JM, Richardson VR, Smith KA, Schroeder V, Somani R, Shore A, Hess K, Ajjan R, Pease RJ, Keen JN, Standeven KF, Carter AM. Howes JM, et al. Diab Vasc Dis Res. 2012 Jul;9(3):216-25. doi: 10.1177/1479164111432788. Epub 2012 Jan 17. Diab Vasc Dis Res. 2012. PMID: 22253322
• The molecular identification of factor H and factor I molecules in rainbow trout provides insights into complement C3 regulation.

  Anastasiou V, Mikrou A, Papanastasiou AD, Zarkadis IK. Anastasiou V, et al. Fish Shellfish Immunol. 2011 Sep;31(3):491-9. doi: 10.1016/j.fsi.2011.06.008. Epub 2011 Jun 15. Fish Shellfish Immunol. 2011. PMID: 21703349
• Experimental confirmation of the C3 tickover hypothesis by studies with an Ab (S77) that inhibits tickover in whole serum.

  Lachmann PJ, Lay E, Seilly DJ. Lachmann PJ, et al. FASEB J. 2018 Jan;32(1):123-129. doi: 10.1096/fj.201700734. Epub 2017 Aug 29. FASEB J. 2018. PMID: 28855277
• [Complement system regulation and C3 glomerulopathy].

  Xiao HJ, He RJ. Xiao HJ, et al. Beijing Da Xue Xue Bao Yi Xue Ban. 2013 Apr 18;45(2):323-6. Beijing Da Xue Xue Bao Yi Xue Ban. 2013. PMID: 23591359 Review. Chinese.
• [Factor I deficiency].

  Fujita T. Fujita T. Ryoikibetsu Shokogun Shirizu. 2000;(32):250-2. Ryoikibetsu Shokogun Shirizu. 2000. PMID: 11212709 Review. Japanese. No abstract available.